SCHEMBL356452

SCHEMBL356452

C[C@]12CC[C@@H]3c4c(cc(O)cc4[C@@]4(O)CC[C@H]5[C@@H]6CCc7cc(O)ccc7[C@H]6CC[C@@]54C)CC[C@H]3[C@@H]1CC[C@H]2O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.70
ESR2 Q92731 5/20 0.70
HSD17B10 Q99714 4/20 0.70
STS P08842 4/20 0.70
LMNA P02545 3/20 0.70
CYP3A4 P08684 3/20 0.70
TSHR P16473 2/20 0.70
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
ABCB11 O95342 2/20 0.70
NR3C1 P04150 2/20 0.70
SHBG P04278 2/20 0.70
PGR P06401 2/20 0.70
AR P10275 2/20 0.70
CYP2B6 P20813 2/20 0.70
SLC6A4 P31645 2/20 0.70
HTR2B P41595 2/20 0.70
SULT1A1 P50225 2/20 0.70
SLC6A3 Q01959 2/20 0.70
AOX1 Q06278 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1447387 1.00 ESR1 (0.70) ESR1ESR2HSD17B10STSLMNA
SCHEMBL11051798 0.87 ESR1 (0.68) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL18258335 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL19217062 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL7260525 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL24037697 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL15610524 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL10039358 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL7037626 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA
Estradiol SCHEMBL15610005 0.83 ESR1 (1.00) ESR1ESR2HSD17B10STSLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015917-A1 Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy PANTARHEI BIOSCIENCE B.V. (NL) 2012-01-19 US disclosed